A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV

Frontiers in Medicine

Linding Wang¹  Shuo Chen¹  Chang Zhou¹  Bangjie Chen²  Hui Fang³  Xianzheng Zhang⁴  Lingling Zhang⁴  Junfa Yang⁴  Huan Zhou⁵ 

[1] Basic Medical Sciences, Anhui Medical University, Hefei, China;Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China;Department of Pharmacology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China;Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China;National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China;School of Pharmacy, Bengbu Medical College, Bengbu, China;School of Public Foundation, Bengbu Medical University, Bengbu, China;

关键词: COVID-19;    SARS-CoV;    WHO;    MERS-CoV;    PHEIC 3;   

DOI  :  10.3389/fmed.2021.628370

来源: Frontiers

【 摘 要 】

The outbreak of coronavirus disease 2019 (COVID-19) has been spreading rapidly in China and the Chinese government took a series of policies to control the epidemic. Studies found that severe COVID-19 is characterized by pneumonia, lymphopenia, exhausted lymphocytes and a cytokine storm. Studies have showen that SARS-CoV2 has significant genomic similarity to the severe acute respiratory syndrome (SARS-CoV), which was a pandemic in 2002. More importantly, some diligent measures were used to limit its spread according to the evidence of hospital spread. Therefore, the Public Health Emergency of International Concern (PHEIC) has been established by the World Health Organization (WHO) with strategic objectives for public health to curtail its impact on global health and economy. The purpose of this paper is to review the transmission patterns of the three pneumonia: SARS-CoV2, SARS-CoV, and MERS-CoV. We compare the new characteristics of COVID-19 with those of SARS-CoV and MERS-CoV.

【 授权许可】

CC BY